Michael P. Gorga

TL;DR: An approach is described that allows one to assign to any measured DPOAE value the probability that the response is coming either from the distribution of normal or impaired responses, thus potentially enabling one to differentiate hearing losses over this range.

TL;DR: All three neonatal hearing screening tests resulted in low refer rates, especially if referrals for follow-up were made only for the cases in which stopping criteria were not met in both ears.

TL;DR: Wave-V latencies decreased with increases in both frequency and level for frequencies from 250 to 8000 Hz and for levels from 20 to 100 dB SPL and the standard deviations seldom exceeded 10% of the mean wave-V latency for any combination of level and frequency.

TL;DR: It would appear that DPOAE measurements can be used to accurately identify the presence of high-frequency hearing loss, but are not accurate predictors of hearing status at lower frequencies, at least for the conditions of the present measurements.

TL;DR: It is suggested that TEOAEs will be valuable for clinical use because of their repeatability and identification of hearing-impaired ears.